AUC Calculator (Pharmacokinetics)

AUC represents the total amount of drug that reaches the systemic circulation over a defined period, expressed as the product of concentration and time (e.g., mg·h/L). A higher AUC indicates greater drug exposure, which may be therapeutically beneficial or toxic depending on the drug and clinical context. AUC is intimately tied to pharmacokinetic parameters including clearance (CL = Dose / AUC) and bioavailability (F = AUC_oral / AUC_IV), making it indispensable for both pharmacokinetic modeling and clinical dosing decisions.

The linear trapezoidal method is the most common numerical approach for estimating AUC from discrete concentration-time data points. For each consecutive pair of time points, a trapezoid is constructed where the two parallel sides are the concentrations C_i and C_{i+1}, and the height is the time interval Δt = t_{i+1} − t_i. The area of each trapezoid is (C_i + C_{i+1}) / 2 × Δt, and the total AUC is the sum of all individual trapezoid areas. For the declining phase of a concentration curve, the log-linear trapezoidal method (using the logarithmic mean of two concentrations) may be preferred for greater accuracy, especially when concentrations are falling rapidly.

In practice, AUC calculations support therapeutic drug monitoring (TDM) programs for antimicrobials, oncology agents, and transplant medications. For example, AUC-guided vancomycin dosing targets an AUC/MIC ratio of 400–600 mg·h/L to optimize efficacy against MRSA while minimizing nephrotoxicity. Similarly, mycophenolate mofetil dosing in transplant patients is often adjusted based on AUC to balance immunosuppression against adverse effects. Regulatory agencies such as the FDA and EMA require AUC data in bioequivalence studies to demonstrate that generic formulations produce equivalent drug exposure to branded products.

The linear trapezoidal method assumes that concentrations change linearly between sampling points, which can overestimate AUC during rapidly declining (log-linear) phases of drug elimination. For more accurate results in the elimination phase, the log-linear trapezoidal rule should be used, where the denominator uses the natural log difference of consecutive concentrations. This calculator does not extrapolate AUC beyond the last measured time point (AUC₀→∞); extrapolation requires estimation of the terminal elimination rate constant (λz) using log-linear regression, which is beyond the scope of a simple trapezoidal tool. Additionally, AUC estimates are highly sensitive to sampling timing errors — delays in blood collection relative to planned times can significantly distort the concentration-time profile. This tool accepts up to four time points; for full pharmacokinetic profiles with many samples, dedicated software such as Phoenix WinNonlin, Monolix, or NONMEM is recommended. Results should always be interpreted by a qualified clinical pharmacist or pharmacokineticist in the context of patient-specific factors including renal function, body weight, and drug-drug interactions.